Back to search

Article

A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care

2025-10-23

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> exome (ES) or genome (GS) sequencing are recommended as first- or second-tier molecular tests for patients with developmental disorders (DD), but the clinical utility of GS continues to be debated. <h4>Methods</h4> This prospective randomized trial involving all Belgian Human Genetics centers compared the standard of care (SoC) - combining ES and chromosomal microarray anal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
da183899-0d52-59d4-8212-f8ca3301e231
DOI
10.1101/2025.10.18.25328208
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of careDOI 10.1101/2025.10.18.25328208
Select a neighboring publication to make it the new centre.